AQUA BIO TECHNOLOGY ASA: årsregnskap 2022 vs 2021
Cash halved-plus
approved 2023-04-27; registry 2023-08-26; journal 2023 717071
Summary
What changed
Comparing Årsregnskap 2022 with 2021 for AQUA BIO TECHNOLOGY ASA. Revenue 975.6k NOK → 941.7k NOK (-3.5%). Net result -19.60m NOK → -18.74m NOK. Equity 18.22m NOK → -5.33m NOK.
On the constructive side: owners injected capital. Pressures included: revenue fell; operating result weakened; equity eroded.
Also worth watching: thin equity buffer; sharp cash drawdown; book investments changed. All figures are taken from the published annual accounts for AQUA BIO TECHNOLOGY ASA.
At a glance
Scorecard
What improved
-
↑
Owners injected capital
Paid-in equity rose 51.53m NOK → 51.65m NOK (+125.0k NOK). Reported fact
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 975.6k NOK to 941.7k NOK (-3.5% YoY). Calculated
-
↓
Operating result weakened
Operating result -18.35m NOK → -22.29m NOK (op. margin -1880.6% → -2367.1%). Calculated
-
↓
Equity eroded
Book equity 18.22m NOK → -5.33m NOK (equity ratio 53.3% → -9.4%). Calculated
-
↓
Cash fell
Bank deposits 13.36m NOK → 1.28m NOK (-90.4% YoY). Calculated
-
↓
Current ratio dropped below 1×
Current ratio 1.78× → 0.36× — short-term liabilities now exceed liquid/current assets on the published lines. Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is -9.4% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation
-
·
Sharp cash drawdown
Cash fell by more than 60% YoY (13.36m NOK → 1.28m NOK). Check whether funds moved to group receivables, investments, or operating burn. Interpretation
-
·
Book investments changed
Investment / intangible book value 0 NOK → 39.91m NOK. Reported fact